Castle Biosciences

(NASDAQ) CSTL

Current Price$18.68

Market Cap$577.48M

Since IPO (2019)-11%

5 Year-63%

1 Year+9%

1 Month-19%

Castle Biosciences Financials at a Glance

Market Cap

$577.48M

Revenue (TTM)

$339.92M

Net Income (TTM)

$12.83M

EPS (TTM)

$-0.43

P/E Ratio

-44.33

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Price

$18.68

Volume

17,208

Open

$19.06

Price

$18.68

Volume

17,208

Open

$19.06

Previous Close

$18.68

Daily Range

$18.37 - $19.18

52-Week Range

$14.59 - $44.28

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Price

$18.68

Volume

17,208

Open

$19.06

Previous Close

$18.68

Daily Range

$18.37 - $19.18

52-Week Range

$14.59 - $44.28

CSTL News

CSTL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Castle Biosciences

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

883

CEO

Derek J. Maetzold

Website

www.castlebiosciences.com

Headquarters

Friendswood, TX 77546, US

CSTL Financials

Key Financial Metrics (TTM)

Gross Margin

77%

Operating Margin

-10%

Net Income Margin

-4%

Return on Equity

-3%

Return on Capital

-7%

Return on Assets

-2%

Earnings Yield

-2.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$577.48M

Shares Outstanding

30.33M

Volume

17.21K

Avg. Volume

392.43K

Financials (TTM)

Gross Profit

$273.20M

Operating Income

$42.81M

EBITDA

$11.34M

Operating Cash Flow

$64.35M

Capital Expenditure

$36.02M

Free Cash Flow

$28.33M

Cash & ST Invst.

$299.50M

Total Debt

$36.91M

Castle Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$83.68M

-4.9%

Gross Profit

$60.38M

-15.7%

Gross Margin

72.15%

N/A

Market Cap

$577.48M

N/A

Market Cap/Employee

$736.59K

N/A

Employees

784

N/A

Net Income

$14.52M

+43.8%

EBITDA

$14.41M

-510.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$224.96M

-9.8%

Accounts Receivable

$42.26M

-25.0%

Inventory

$10.46M

+52.7%

Long Term Debt

$33.80M

+45.1%

Short Term Debt

$2.92M

+14.7%

Return on Assets

-2.34%

N/A

Return on Invested Capital

-6.67%

N/A

Free Cash Flow

$34.58M

-220.9%

Operating Cash Flow

$22.13M

-266.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PSNLPersonalis, Inc.

PSNLPersonalis, Inc.$6.04+4.50%

EVHEvolent Health, Inc.

EVHEvolent Health, Inc.$4.16+5.05%

FLGTFulgent Genetics, Inc.

FLGTFulgent Genetics, Inc.$15.80-0.13%

MYGNMyriad Genetics, Inc.

MYGNMyriad Genetics, Inc.$4.07-3.33%

GERNGeron Corporation

GERNGeron Corporation$1.40+0.72%

EMBCEmbecta Corp.

EMBCEmbecta Corp.$3.41+1.49%

DRIODarioHealth Corp.

DRIODarioHealth Corp.$8.68+8.77%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

QUBTQuantum Computing

QUBTQuantum Computing$11.78+0.16%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.96-0.05%

NOKNokia

NOKNokia$13.17-0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.96-0.03%

WOKWork Medical Technology Group Ltd

WOKWork Medical Technology Group Ltd$6.66+0.70%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.31+0.03%

IRENIren

IRENIren$56.56+0.03%

Questions About CSTL

What is the current price of Castle Biosciences?

Castle Biosciences is trading at $18.69 per share.

What is the 52-week range for Castle Biosciences?

Over the past 52 weeks, Castle Biosciences has traded between $14.59 and $44.28.

How much debt does Castle Biosciences have?

As of the most recent reporting period, Castle Biosciences reported total debt of $36.72M.

How much cash does Castle Biosciences have on hand?

Castle Biosciences reported $63.76M in cash and cash equivalents in its most recent financial results.

What is Castle Biosciences’s dividend yield?

Castle Biosciences does not currently have a dividend yield.

Castle Biosciences

Castle Biosciences Financials at a Glance

CSTL News

Castle (CSTL) Q2 Revenue Tops Estimates

Why Castle Biosciences Stock Is Jumping Today

Why Shares of Castle Biosciences Fell This Week

Why Castle Biosciences Stock Is Crushing It Today

Why Shares of Castle Biosciences Plummeted on Monday

Why Shares of Castle Biosciences Slumped This Week

CSTL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Castle Biosciences

CSTL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Castle Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CSTL

What is the current price of Castle Biosciences?

What is the 52-week range for Castle Biosciences?

How much debt does Castle Biosciences have?

How much cash does Castle Biosciences have on hand?

What is Castle Biosciences’s dividend yield?

Premium Investing Services